Obinutuzumab Β

Clinical trials for Obinutuzumab Β explained in plain language.

Never miss a new study

Get alerted when new Obinutuzumab Β trials appear

Sign up with your email to follow new studies for Obinutuzumab Β, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Experimental drug aims to tame rare nerve disorder

Disease control Not yet recruiting

This trial tests a drug called obinutuzumab β in people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), a condition where the immune system attacks nerves, causing weakness and numbness. Participants receive two intravenous infusions of the drug and are mon…

Matched conditions: OBINUTUZUMAB Β

Phase 1/2 • Sponsor: Zhongming Qiu • Aim: Disease control

Last updated Jul 12, 2026 00:00 UTC

Obinutuzumab Β

Get alerted when new Obinutuzumab Β trials appear

Experimental drug aims to tame rare nerve disorder